Lilly Reports Fourth-Quarter 2022 Financial Results, Core Business Growth and Pipeline Advancements Support Strong Long-Term Outlook

Go back to Lilly Reports Fourth-Quarter 2022 Financial Results, Core Business Growth and Pipeline Advancements Support Strong Long-Term Outlook

Eli Lilly & Co. (LLY) Tops Q4 EPS by 29c, Lifts Outlook

February 2, 2023 6:57 AM EST

Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $2.09, $0.29 better than the analyst estimate of $1.80. Revenue for the quarter came in at $7.3 billion versus the consensus estimate of $7.35 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2023 EPS of $8.35-$8.55, versus... More